Search Results for "risperdal"
- J&J must pay $181M as part of Medicare fraud case
Johnson & Johnson has been ordered to pay $181 million to a Houston law firm that worked on behalf of the state of Arkansas in a Medicare fraud case against the company. A Reuters story says that payment is part of a $1.2 billion settlement the company agreed to pay Arkansas in 2012, based on th...
- Pa. state employee tried to warn of kickbacks
The Philadelphia Inquirer reports that an investigator employed by the state of Pennsylvania twice tried to warn that state employees were getting kick-backs from pharmaceutical companies. Both times, according to the Inquirer, Pennsylvania state government officials dismissed Allen Jones and his in...
- J&J settles lawsuits over harmed patients
Johnson & Johnson has agreed to settle five lawsuits in Philadelphia Court of Common Pleas, based on claims that its antipsychotic drug Risperdal caused five boys to grown breast tissue. Terms of the settlement weren’t disclosed, Bloomberg reports. The lawsuits are among more than 400 in which...
- J&J CEO gets out of testifying in trial
The Philadelphia Inquirer reports that lawyers representing pharmaceutical giant Johnson & Johnson successfully quashed a subpoena to compel CEO Alex Gorsky to testify about allegations that inappropriate marketing harmed children taking the company’s drugs. The case involves a 17-year-old boy...
- Former manager: J&J encouraged illegal tactics
A former Johnson & Johnson sales manager testified that the company promoted the illegal marketing of its antipsychotic drug Risperdal through tactics such as paying doctors to give favorable speeches and subsidizing golf trips, Bloomberg reports. In 2003, company officials specifically urged sa...
- Court refuses to throw out J&J fine
According to Bloomberg, a Louisiana appeals court declined to throw out an award of nearly $258 million that Johnson & Johnson must pay to state officials, over illegal marketing of its antipsychotic drug Risperdal. Jurors in Louisiana found Johnson & Johnson officials violated the state’s...
- Government launches more inquiries into J&J
Even as Johnson & Johnson is settling previous charges that may cost about $2.2 billion, the government is making new inquiries into allegations that the company used illegal tactics to promote and market its drugs, the Wall Street Journal reports. According to the Wall Street Journal, the U.S. ...
- Despite problems, Johnson & Johnson making money
The investment blog Seeking Alpha says Johnson & Johnson is doing quite well financially despite its recent problems – including high-profile and costly recalls of faulty medical devices. The report notes that Warren Buffett’s Berkshire Hathaway Inc. dropped two-thirds of its holdings in the...
- J&J to pay $181 million in illegal marketing settlement
Johnson & Johnson will pay 36 states and the District of Columbia $181 million as a settlement for allegations that the company inappropriately marketed its antipsychotic drug Risperdal, the Philadelphia Inquirer reports. Federal and state investigators have been examining the company’s Ri...
- Individual charges rare in corporate fraud cases
According to a story in the New York Times, a renewed U.S. Justice Department emphasis on prosecuting corporate fraud is expected to bring in as much as $8 billion this year from pharmaceutical companies, military contractors, banks and other corporations charged with defrauding the government, whic...
